Few overheating or already-surging signals — relatively calm. A good stage to observe pre-breakout conditions patiently.
Some risk factors present — volatility, short-term overheating, or thin liquidity. Size and scale in carefully if entering.
Already surged, RSI overheated, extended far from highs, or earnings imminent. Chasing now carries meaningful pullback risk.
CGEN's RSI(14) currently reads 52. RSI is a momentum indicator that reflects how often and how sharply a stock has been rising lately. Readings above 70 are typically read as overbought and below 30 as oversold — this one falls in the 'normal' range. Cross-check this against CGEN's other indicators above before drawing a conclusion. → Learn more
ADX currently reads 17. ADX tells you how convincing a trend is, leaving the up-or-down call to +DI/-DI (25+ is considered pronounced). Right now CGEN shows +DI sits above -DI, favoring the upside, putting it in the 'weak trend' range on ADX. This reading is specific to CGEN on this scan date and can change quickly. → Learn more
CGEN's Bollinger Band width is at the 46th percentile (mid-range) of its past year, and the squeeze indicator is not currently active. Band-width contraction (a squeeze) means the stock has been trading in an unusually tight range lately. A squeeze is often followed by a volatility expansion in either direction. Cross-check this against CGEN's other indicators above before drawing a conclusion. → Learn more
CGEN's OBV is currently not showing a clear rise (none), and the up/down volume ratio is 1.2x. OBV is a running tally that infers buying or selling pressure purely from volume direction. As with any single metric, weigh this alongside CGEN's full indicator set. → Learn more
CGEN's recent volume is running at 0.6x its usual level. The volume ratio compares recent trading volume to the stock's usual average volume — a reference point for whether order flow is concentrating around this stock. As with any single metric, weigh this alongside CGEN's full indicator set. → Learn more
CGEN's change over the last 5 trading days is +0.0%, and over the last 1 trading day is -1.2%. These two numbers show recent short-term direction but say nothing about where the price goes next.
CGEN's current price is 12.9% below its 20-day high. Distance from the recent high is a reference point for how close price is to potential resistance. On this measure it currently falls in the 'distance from high' category. Treat this as one data point on CGEN, not a standalone signal. → Learn more
CGEN's ATR% currently reads 4.7%, a 'daily range' level. ATR% expresses how large the average daily move has been recently, as a percentage of price. This reading is specific to CGEN on this scan date and can change quickly. → Learn more
CGEN's 20-trading-day relative strength versus SPY (S&P 500 ETF) is +10.2%. CGEN held up better than the S&P 500 over this particular window. Cross-check this against CGEN's other indicators above before drawing a conclusion. → Learn more
Stocks holding +DI Dominance reached +15% 27.0% of the time, versus a 29.3% base rate — not a statistically significant difference (8370 cases). As with any single metric, weigh this alongside CGEN's full indicator set. → +DI Dominance
Measured (n=5281), the hit-rate for Weekly Squeeze (25.4%) was not statistically distinguishable from the base rate (29.3%). Treat this as one data point on CGEN, not a standalone signal. → Weekly Squeeze
Measured (n=3350), the hit-rate for Relative Strength +8pp (20D) (34.6%) was not statistically distinguishable from the base rate (29.3%). This reading is specific to CGEN on this scan date and can change quickly. → Relative Strength +8pp (20D)
No significant edge was measured for Stage 2 Trend Template: 21.4% versus a 29.3% base rate across 1385 cases. Treat this as one data point on CGEN, not a standalone signal. → Stage 2 Trend Template
Measured across 2502 cases, stocks with Avg Daily Range 4%+ reached +15% within 20 trading days 59.5% of the time — significantly higher than the 29.3% base rate. Cross-check this against CGEN's other indicators above before drawing a conclusion. → Avg Daily Range 4%+
Limitations of this page — Automatically calculated, not a stock recommendation. Score is a count of conditions met, not a prediction; base rates are historical measurements only (CGEN diagnostic as of 2026.09.09 13:05).
A history of past monitoring candidates — not investment advice. See the scanner's full track record here.